<DOC>
	<DOCNO>NCT00165204</DOCNO>
	<brief_summary>Women undergo surgical menopause often experience mark menopausal side effect reluctant use estrogen female hormone ease transition menopause worry hormone may increase breast cancer risk . This study evaluate tibolone woman experience surgical menopause ass effect bone health , menopause symptom breast density .</brief_summary>
	<brief_title>Effects Tibilone Bone Density , Menopause Symptoms Breast Density Women After Prophylactic Oophorectomy</brief_title>
	<detailed_description>Women interested participate study allow use hormone manage symptom 3 month begin study . Those choose take hormone may enroll study immediately . All woman baseline mammogram , breast examination , bone study density perform , along blood urine analysis measurement bone marker . They also ask take questionnaire . Patients take either tibolone placebo daily 1 year . Neither patient physician aware treatment woman take study . Patients return 6 12 month physical examination , blood work , urine collection bone study . At one year , repeat mammogram perform . There also questionnaires ask menopause symptom perform interval study . It also recommend patient take calcium vitamin D throughout study .</detailed_description>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Tibolone</mesh_term>
	<criteria>Good overall health Premenopausal time enrollment oophorectomy Will undergo undergone oophorectomy Negative breast examination negative breast image study History breast cancer , ductal carcinoma situ ( DCIS ) cancer except carcinoma situ cervix basal cell carcinoma skin History ovarian cancer , breast cancer ( DCIS ) malignancy Low bone mass compare ageadjusted control Current recent exposure ( within 3 month ) medication alter bone metabolism Estrogens , progesterone , androgen , tamoxifen raloxifene within 3 month randomization History significant medical problem potentially related estrogen History Paget 's disease bone , ankylose spondylitis , rheumatoid arthritis metabolic bone disease , vitamin D deficiency , hyperparathyroidism , newly diagnose hyperthyroidism Body mass index ( BMI ) &gt; 32 Highdensity lipoprotein ( HDL ) cholesterol &lt; 40 mg/dl Women whose uterus retain history uterine abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Tibolone</keyword>
	<keyword>High risk woman</keyword>
	<keyword>Oophorectomy</keyword>
	<keyword>Breast Density</keyword>
	<keyword>Bone Density</keyword>
</DOC>